Get started
Author

Gabriele Aitoro

Observed names: Aitoro G, G Aitoro, G. AITORO, G. Aitoro
OpenAlex ID: A5067687613
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score
2021 · Mattia D’Agostino, Alessandra Larocca, et al. · Blood Cancer Journal · 15
PDF
Early Mortality in Elderly Patients With Newly Diagnosed Multiple Myeloma Treated With Novel Agents
2015 · A. Larocca, S. Bringhen, et al. · Clinical Lymphoma Myeloma & Leukemia · 8
The Weekly Infusion of Bortezomib Reduces Peripheral Neuropathy.
2009 · Francesca Gay, Sara Bringhen, et al. · Blood · 7
Bortezomib, Melphalan, Prednisone and Thalidomide (Vmpt)versus Bortezomib, Melphalan and Prednisone (Vmp) Inelderly Newly Diagnosed Myeloma Patients: A Prospective,randomized, Phase Iii Study
2009 · Antonio Palumbo, Sara Bringhen, et al. · Institutional Research Information System University of Turin (University of Turin) · 7
Successful use of recombinant factor VIIa in a patient with paraneoplastic factor XI inhibitor
2007 · G. DELIOS, B. POLLIO, et al. · Haemophilia · 1
Autografting Followed by Low Dose Tbi Based Non Myeloablative Allografting in Newly Diagnosed Multiple Myeloma: the Italian Experience
2003 · Benedetto Bruno, Francesca Patriarca, et al. · Institutional Research Information System University of Turin (University of Turin) · 1
The Combination of Frailty and ISS Scores Identifies a Simple Prognostic Index for Overall Survival in Elderly Patients Treated with Novel Agents-Based Induction Therapy
2014 · Alessandra Larocca, Sara Bringhen, et al. · Blood
Suspension of Vitamin K Antagonists Is Not Required for Cataract Surgery: A Prospective Study in a Cohort of 135 Consecutive Patients on Long-Term Anticoagulant Therapy.
2006 · Berardino Pollio, Giuseppe A. Demarie, et al. · Blood
Exhaled Nitric Oxide (eNO) and Pulmonary Function after Total Body Irradiation (TBI) Based Non Myeloablative Conditioning Regimens and Allogeneic Hematopoietic Cell Transplant.
2005 · Luisa Giaccone, Caterina B. Bucca, et al. · Blood
Exhaled Nitric Oxide and Pulmonary Complications After Allogeneic Stem Cell Transplantation
2005 · C. BUCCA, L. BRUSSINO, et al.
Exhaled nitric oxide (eNO) and pulmonary function after total body irradiation (TBI) based non myeloablative conditioning regimens and allogenic hematopoietic cell transplant
2005 · GIACCONE, Luisa, Bucca CB, et al. · Institutional Research Information System University of Turin (University of Turin)
Low Dose TBI Based Nonmyeloablative Conditionings for Allografting in Multiple Myeloma: Impact of Disease Status at Transplant.
2004 · Luisa Giaccone, Marcello Rotta, et al. · Blood
Low-dose Tbi-based Non-myeloablative Allografting in Newly Diagnosed Multiple Myeloma
2004 · Benedetto Bruno, Francesca Patriarca, et al. · Institutional Research Information System University of Turin (University of Turin)
Molecular monitoring of minimal residual disease after non-myeloablative allografting for multiple myeloma
2003 · B Bruno, Marco Ladetto, et al. · Institutional Research Information System University of Turin (University of Turin)
Autografting Followed by Low Dose Tbi Based Non Myeloablative Allografting in Multiple Myeloma: the Gitmo Experience
2003 · Benedetto Bruno, Francesca Patriarca, et al. · Institutional Research Information System University of Turin (University of Turin)
Tandem transplant with autografting followed by non-myeloablative allografting for treatment of multiple myeloma: an Italian multi center trial
2003 · BRUNO, Benedetto, AGLIETTA, Massimo, et al. · Institutional Research Information System University of Turin (University of Turin)
Autografting Followed by Non Myeloablative Tbi-based Allograting for Treatment of Multiple Myeloma: a Multi-center Trial
2002 · Benedetto Bruno, Francesca Patriarca, et al. · Institutional Research Information System University of Turin (University of Turin)
Cytofluorimetric Monitoring of Minimal Residual Disease Can Predict Clinical Remission in Multiple Myeloma Patients Undergoing Non Myeloablative Allogeneic Transplantation
2002 · Paola Omedè, Benedetto Bruno, et al.
Cytofluorimetric Monitoring of Minimal Residual Disease Can Predict Clinical Remission in Multiple Myeloma Patients Undergoing Non Myeloablative Allogeneic Transplantation
2002 · Omedè P, Giaretta F, et al. · Institutional Research Information System University of Turin (University of Turin)
Molecular Remission in a Multiple Myeloma Patient After a Non Myeloablative Allogeneic Transplant: Proof of Principle
2001 · Benedetto Bruno, Marco Ladetto, et al. · Institutional Research Information System University of Turin (University of Turin)
Works count: 21
Citation count: 39
H-index: 4
I10-index: 1
Year
Topic
Type